Biggest News Aggregation in the World
📰 Phase 2 News

Page 8 - Phase 2 News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phase 2. Real-time updates on events, politics, business and more.

Q&A: Combination OCA-Bezafibrate for PBC, with Cynthia Levy, MD

Cynthia Levy, MD, professor of medicine at the University of Miami, provided further insight into unmet needs in PBC, the use of OCA-bezafibrate in PBC, and the significance of results from a pair of phase 2 studies presented at The Liver Meeting.
United States University Of Miami American Porphyria Foundation Cynthia Levy American Porphyria Foundation Cynthia Levy Liver Meeting

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Janssen's antibody drug shows phase 2 potential in rheumatoid arthritis

The proof-of-concept trial, dubbed IRIS-RA, is the first to investigate a treatment for rheumatoid arthritis that blocks a protein called neonatal Fc receptor (FcRn). The antibody drug nipocalimab, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, has shown early promise for treating rheumatoid arthritis (RA) in a phase 2a trial.
Peterc Taylor Norman Collisson University Of Oxford Momenta Pharmaceuticals American College Of Rheumatology Disease Activity Score

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science